• LAST PRICE
    1.8400
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-1.0753%)
  • Bid / Lots
    1.8100/ 5
  • Ask / Lots
    1.8500/ 4
  • Open / Previous Close
    1.8500 / 1.8600
  • Day Range
    Low 1.8300
    High 1.8600
  • 52 Week Range
    Low 1.1600
    High 3.2550
  • Volume
    98,437
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.86
TimeVolumeIMAB
09:32 ET23861.85
09:36 ET1001.86
09:39 ET3791.85
09:41 ET1001.845
09:43 ET2281.85
09:48 ET11021.8406
09:50 ET2041.845
09:54 ET8831.85
10:03 ET15001.8401
10:10 ET1501.83
10:19 ET33001.84
10:21 ET14401.84
10:26 ET54651.86
10:28 ET3371.855
10:37 ET1001.85
10:46 ET1001.855
10:48 ET25971.8589
10:50 ET6331.8593
10:51 ET8081.855
10:55 ET20211.855
10:57 ET9001.8501
11:00 ET18001.845
11:02 ET2101.845
11:04 ET6851.8499
11:11 ET1501.8475
11:13 ET41281.849
11:18 ET1501.845
11:24 ET4101.8401
11:26 ET1341.845
11:27 ET13261.85
11:36 ET49281.85
11:38 ET1001.85
11:54 ET1001.845
11:56 ET2001.845
11:58 ET28681.8375
12:02 ET1001.84
12:14 ET29001.83
12:16 ET3001.835
12:18 ET48551.8323
12:20 ET33001.83
12:23 ET1001.84
12:27 ET7001.8398
12:36 ET18141.84
12:43 ET1001.84
12:56 ET6711.8399
12:57 ET1001.835
01:10 ET1001.835
01:12 ET14001.8301
01:15 ET1201.835
01:17 ET1201.835
01:21 ET2001.835
01:28 ET1001.835
01:32 ET21001.84
01:33 ET1001.835
01:37 ET1001.835
01:44 ET12001.835
01:46 ET1001.835
01:48 ET1001.835
01:51 ET3001.835
01:57 ET42391.835
02:00 ET22171.83
02:02 ET2001.835
02:06 ET1001.835
02:09 ET3121.8399
02:22 ET7001.83
02:26 ET3431.8325
02:29 ET4001.835
02:33 ET5001.84
02:40 ET18001.84
02:42 ET1001.835
02:44 ET8711.8375
02:54 ET19001.8301
02:58 ET10001.83
03:07 ET3001.83
03:16 ET2001.835
03:18 ET1001.835
03:25 ET2561.831
03:27 ET3001.83
03:30 ET2001.8393
03:32 ET1001.8307
03:36 ET14001.83
03:38 ET3291.835
03:45 ET2001.835
03:48 ET3001.835
03:50 ET1001.835
03:52 ET1001.835
03:54 ET1001.835
03:56 ET4061.835
03:57 ET8541.84
03:59 ET17311.84
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMAB
I-Mab
148.8M
-0.8x
---
United StatesPYPD
PolyPid Ltd
20.3M
-0.3x
---
United StatesIBIO
Ibio Inc
22.1M
-0.2x
---
United StatesAPM
Aptorum Group Ltd
24.7M
-5.0x
---
United StatesPMCB
PharmaCyte Biotech Inc
18.3M
-1.3x
---
United StatesKALA
KALA BIO Inc
16.8M
-0.4x
---
As of 2024-06-15

Company Information

I-Mab is a global biotech company. The Company is focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. Its pipeline strategy is to build a risk-controlled clinical-stage pipeline with a focus on novel or highly differentiated biologics. The Company’s pipeline includes Uliledlimab (TJD5), Givastomig (TJ-CD4B), and Ragistomig (TJ-L14B). Uliledlimab (TJD5) is a differentiated, humanized antibody against CD73, an ecto-enzyme expressed on stromal cells and tumors that converts extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab offers clinical benefit by suppressing tumor growth in concert with checkpoint therapies such as PD-(L)1 antibodies. Givastomig is designed as a bispecific antibody to target Claudin 18.2-positive tumor cells, with conditional activation of pro-immune 4-1BB in the tumor microenvironment. Ragistomig is designed as a bispecific antibody to address PD-L1 resistant tumors.

Contact Information

Headquarters
Suite 400, 2440 Research BlvdROCKVILLE, MD, United States 20850
Phone
301-670-2800
Fax
---

Executives

Interim Independent Chairman of the Board
Pamela Klein
Chief Executive Officer, Director
Rajkumar Kannan
Chief Financial Officer
Joseph Skelton
Chief Medical Officer
John Hayslip
Director
Shuai Chen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$148.8M
Revenue (TTM)
$3.8M
Shares Outstanding
80.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.09
EPS
$-2.43
Book Value
$2.93
P/E Ratio
-0.8x
Price/Sales (TTM)
39.1
Price/Cash Flow (TTM)
---
Operating Margin
-5,059.30%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.